Announcements Trials
Browse Landscape

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Myocarditis 1Hematologic Neoplasms 1Adenocarcinoma 1

Interventions

Surveys and Questionnaires 18Blood Specimen Collection 16Specimen Handling 12Observation 6Magnetic Resonance Spectroscopy 6Surgical Procedures, Operative 5Radiotherapy 5trastuzumab deruxtecan 4ribociclib 4darolutamide 4Standard of Care 4Patient Reported Outcome Measures 4Letrozole 4Data Collection 4Cryosurgery 4Breath Tests 4Tomography, X-Ray Computed 3Radiation 3Neoadjuvant Therapy 3Magnetic Resonance Imaging 3Biopsy 3Anastrozole 3lorlatinib 2cemiplimab 2atezolizumab 2Ultrasonography 2Trastuzumab 2Staining and Labeling 2Restraint, Physical 2Positron-Emission Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Positron-Emission Tomography × 30 days × Clear all
NCT06862856 2026-05-15

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Massachusetts General Hospital

Recruiting
50 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06566209 2026-05-08

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Mayo Clinic

Terminated
2 enrolled
Other hematologic neoplasm

Myocarditis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡